实验动物与比较医学 ›› 2026, Vol. 46 ›› Issue (4): 531-540.DOI: 10.12300/j.issn.1674-5817.2025.172

• 人类疾病动物模型 • 上一篇    下一篇

病证结合肺癌小鼠模型研究进展

赵玉磊1(), 韩冰冰1, 王兴鑫2, 杨广建3, 王雅杰3, 唐晓勇3()   

  1. 1.山东中医药大学中医学院, 济南 250355
    2.山东第一医科大学附属山东省立医院中医科, 济南 250021
    3.山东第一医科大学附属肿瘤医院, 济南 250117
  • 收稿日期:2025-10-13 修回日期:2026-02-05 出版日期:2026-08-25 发布日期:2026-08-22
  • 通讯作者: 唐晓勇(1977—),男,博士,主任医师,研究方向:肺癌的内科综合治疗和内科简易胸腔镜的诊断。E-mail:sdtangxiaoyong2025@163.com。ORCID:0009-0001-6580-3096
  • 作者简介:赵玉磊(1996—),女,硕士,研究方向:中西医结合防治肿瘤基础研究。E-mail:2023110073@sdutcm.edu.cn。ORCID:0009-0006-5825-5382
  • 基金资助:
    山东中医药大学硕士研究生提质创新课题“基于‘扶正祛邪’法研究参苓解毒汤治疗Lewis原位肺癌小鼠的作用及机制”(YJSTZCX2025046);山东省中医药科技项目“参苓解毒汤联合PD-1单抗一线治疗NSCLC的随机对照临床研究及基于蛋白质组学的机制探讨”(Z20243905)

Progress in Disease-Syndrome-Integrated Mouse Models of Lung Cancer

ZHAO Yulei1(), HAN Bingbing1, WANG Xingxin2, YANG Guangjian3, WANG Yajie3, TANG Xiaoyong3()   

  1. 1.College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan 250355, China
    2.Department of Traditional Chinese Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan 250021, China
    3.Shandong Cancer Hospital Affiliated to Shandong First Medical University, Jinan 250117, China
  • Received:2025-10-13 Revised:2026-02-05 Published:2026-08-25 Online:2026-08-22
  • Correspondence to: TANG Xiaoyong (ORCID: 0009-0001-6580-3096), E-mail: sdtangxiaoyong2025@163.com

摘要:

肺癌是全球范围内病死率最高的恶性肿瘤,严重威胁人类健康。中医治疗肺癌具有独特优势,而病证结合动物模型是中医肺癌研究的关键环节。根据中医病因病机,肺癌属本虚标实之证,临床常分为气阴两虚证、肺脾气虚证、肺阴虚证、气滞血瘀证、痰热阻肺证等证型,治疗应以“扶正祛邪”为根本法则。本文系统检索了2005—2025年病证结合肺癌动物模型相关文献,总结了气阴两虚型、脾气虚型、气滞血瘀型、肾虚型4类核心病证结合模型的构建理论依据与制备方法,并进一步讨论了各自的评价体系及局限性。此外,本文还总结了阳虚型、脾虚型、气虚血瘀型等其他病证结合模型的造模方式,从行为学特征和生化指标归纳了模型评价方法。分析结果表明,当前模型多以C57BL/6小鼠为造模对象,存在临床吻合度不足、造模方法复杂、干扰因素多、标准化程度低等问题,提出了未来病证结合肺癌动物模型的改进方向:可利用成簇规律间隔短回文重复序列技术(clustered regularly interspaced short palindromic repeats,CRISPR)建立类器官-患者来源的异种移植物模型;构建可控性复合应激体系,开发如梯度温控寒热交替箱、程序化饮食调控系统等标准化刺激模块,减少非特异性干扰;在发展多维度动态造模技术方面,整合代谢组学、影像特征等临床大数据设计动态干预方案,为阐释中医防治肺癌作用机制提供更精准、更可靠的实验工具。

关键词: 肺癌, 病证结合, 小鼠模型, 中医证候

Abstract:

Lung cancer has the highest mortality rate among malignant tumors worldwide, posing a severe threat to human health. Traditional Chinese medicine (TCM) offers unique advantages in treating lung cancer, with disease-syndrome-integrated animal models serving as a critical component of TCM lung cancer research. According to TCM pathogenesis, lung cancer is classified as a pattern of underlying deficiency with superficial excess. Clinically, it is often categorized into syndromes such as qi and yin deficiency, lung-spleen qi deficiency, lung yin deficiency, qi stagnation and blood stasis, and phlegm-heat obstructing the lungs. Treatment should fundamentally adhere to the principle of "strengthening the healthy qi and expelling pathogenic factors". This paper systematically reviews literature from 2005 to 2025 on disease-syndrome-integrated animal models for lung cancer. It summarizes the theoretical basis and establishment methods of four core disease-syndrome-integrated models: qi-yin deficiency pattern, spleen qi deficiency pattern, qi stagnation and blood stasis pattern, and kidney deficiency pattern. Further discussion covers their evaluation systems and limitations. Additionally, modeling approaches for other patterns including yang deficiency, spleen deficiency, and qi deficiency with blood stasis are summarized, with evaluation methods categorized by behavioral characteristics and biochemical indicators. Analysis reveals that current models predominantly use C57BL/6 mice, exhibiting issues such as insufficient clinical relevance, complex modeling procedures, numerous confounding factors, and a low degree of standardization. Future improvements to disease-syndrome-integrated lung cancer animal models could include using clustered regularly interspaced short palindromic repeats (CRISPR) technology to establish organoid–patient-derived xenograft models; developing controllable composite stress systems and standardized stimulus models, such as gradient-controlled alternating cold/heat chambers and programmed dietary regulation systems, to reduce nonspecific interference; and developing multidimensional dynamic modeling techniques by integrating clinical big data, including metabolomics and imaging features, to design dynamic intervention protocols, thereby providing more precise and reliable experimental tools for elucidating the mechanisms of TCM in lung cancer prevention and treatment.

Key words: Lung cancer, Disease-syndrome integration, Mouse model, Traditional Chinese medicine syndrome

中图分类号: